尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Vakiener Victoria, Director. Officer active across 1 company, notably Arrowhead Pharmaceuticals, INC.. Aggregated, 12 filings have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €1m. History available since 10 January 2023. The latest transaction was filed on 19 December 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Vakiener Victoria serves as a Director at ARROWHEAD PHARMACEUTICALS, INC. In this role, she contributes to the governance and strategic direction of the company. Her experience in the biopharmaceutical sector allows her to provide valuable insights on growth and innovation opportunities. Victoria plays a key role in overseeing operations and evaluating company performance.